X
04Mar

HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums

In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By: Foley & Lardner LLP
Source Url: https://www.jdsupra.com/legalnews/hhs-gives-new-guidance-on-drug-21788/

Related

Key Takeaways from Manufacturing Dealmaker Perspectives Webinar

The sudden arrival of the COVID-19 pandemic in the first quarter of 2020 shocked an M&A market that ...

Read More >

GP-Led Single Asset Deals

Over the last five years, many private equity market participants have become acquainted with a “GP...

Read More >

[Video] Great Women in Compliance-Episode 24: Andrea Bonime Blanc

In this episode of Great Women in Compliance, Lisa speaks with Andrea Bonime Blanc, who has "done it...

Read More >

National Census of Fatal Occupational Injuries Released

Seyfarth Synopsis: The U.S. Bureau of Labor Statistics (BLS) recently released its annual National C...

Read More >

FTC Proposed HSR Amendment Could Make It Easier For Activist Investors And Hostile Bidders To Keep Positions Confidential From Issuers

On September 21, 2020, the Federal Trade Commission (the “FTC”) announced proposed amendments that...

Read More >

Where There's Smoke: How Employers Can Navigate Employees' Cannabis Use

According to the most recent statistics from the Canadian Cannabis Survey (CCS), 5% of people survey...

Read More >